Compound Summary
Prilocaine hydrochloride
Compound Information
Prilocaine hydrochloride
Compound Name: | Prilocaine hydrochloride |
Compound CID: | 92163 |
Synonyms: | Prilocaine hydrochloride 1786-81-8 Propitocaine hydrochloride Prilocaine HCl Xylonest More... |
Iupac Name: | N-(2-methylphenyl)-2-(propylamino)propanamide;hydrochloride |
InChI: | InChI=1S/C13H20N2O.ClH/c1-4-9-14-11(3)13(16)15-12-8-6-5-7-10(12)2;/h5-8,11,14H,4,9H2,1-3H3,(H,15,16);1H |
InChIKey: | BJPJNTKRKALCPP-UHFFFAOYSA-N |
Canonical Smiles: | CCCNC(C)C(=O)NC1=CC=CC=C1C.Cl |
Isomeric Smiles: | CCCNC(C)C(=O)NC1=CC=CC=C1C.Cl |
Molecular Weight: | 256.77 |
Molecular Formula: | C13H21ClN2O |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Prilocaine hydrochloride
Molecular Weight: | 256.77 |
Molecular Formula: | C13H21ClN2O |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 5 |
Heavy Atom Count: | 17 |
Complexity: | 218 |
Synonyms
Prilocaine hydrochloride
| Prilocaine hydrochloride | Prilocaine hydrochloride |
|---|---|
Prilocaine hydrochloride |
1786-81-8 |
Propitocaine hydrochloride |
Prilocaine HCl |
Xylonest |
Prilocaine (hydrochloride) |
Prilocaine, HCl |
MFCD00079279 |
2-(Propylamino)- |
N-(2-Methylphenyl)-2-(propylamino)propanamide hydrochloride |
N-(2-methylphenyl)-2-(propylamino)propanamide;hydrochloride |
878791-35-6 |
2-(Propylamino)-m-propionotoluidide Hydrochloride |
2-(Propylamino)-o-propionotoluidide hydrochloride |
L-67 |
MLS000069690 |
Prilocaine chloride |
SMR000058506 |
Citanest hydrochloride |
Citanest plain |
2-(Propylamino)-o-propionotoluidide monohydrochloride |
alpha-Propylamine-2-methyl-propionanilide hydrochloride |
DSSTox_CID_11956 |
DSSTox_RID_78897 |
DSSTox_GSID_31956 |
CHEBI:32053 |
SR-01000076094 |
EINECS 217-244-0 |
2-(Propylamino)-N-(o-tolyl)propanamide hydrochloride |
Citanest (TN) |
Prestwick_616 |
Prilocaine hydrochloride USAN:USP |
o-Propionotoluidide, 2-(propylamino)-, monohydrochloride |
Propitocainehydrochloride |
Opera_ID_480 |
NCGC00016594-01 |
Propanamide, N-(2-methylphenyl)-2-(propylamino)-, hydrochloride (1:1) |
Propanamide, N-(2-methylphenyl)-2-(propylamino)-, monohydrochloride |
CAS-1786-81-8 |
DL-(+-)-Prilocaine HCl |
MLS002222230 |
MLS002548864 |
ARONIS24439 |
SCHEMBL330180 |
SPECTRUM1503270 |
2-(Propylamino)-N-(o-tolyl)propionamide Hydrochloride |
AMY587 |
Prilocaine hydrochloride (USP) |
CHEMBL1200586 |
DTXSID2031956 |
NIOSH/TX1480000 |
HY-B0137A |
Propitocaine hydrochloride (JAN) |
EBD2408 |
DL-(+-)-Prilocaine hydrochloride |
HMS1568H19 |
HMS1922O15 |
Pharmakon1600-01503270 |
Prilocaine HCl (Propitocaine HCl) |
ACT04757 |
BCP22337 |
EX-A2857 |
Tox21_110513 |
Tox21_501005 |
CCG-39327 |
NSC758432 |
s5482 |
AKOS015895106 |
Tox21_110513_1 |
AC-2099 |
CS-1930 |
KS-5024 |
LP01005 |
MCULE-7993425453 |
NC00474 |
NSC 758432 |
NSC-758432 |
NCGC00015860-06 |
NCGC00094299-01 |
NCGC00094299-02 |
NCGC00094299-03 |
NCGC00094299-04 |
NCGC00094299-05 |
NCGC00261690-01 |
BP166249 |
Prilocaine hydrochloride, >=98% (TLC) |
SY066795 |
BCP0726000006 |
AB0005494 |
EU-0101005 |
FT-0633840 |
P2038 |
ST51015112 |
TX14800000 |
D01243 |
J10292 |
P 9547 |
2-(propylamino)-N-o-tolylpropanamide hydrochloride |
786P818 |
A812391 |
Q-201619 |
SR-01000076094-1 |
SR-01000076094-6 |
N-(2-methylphenyl)-N2-propylalaninamide hydrochloride |
Q27114764 |
N-(2-methylphenyl)-2-(propylamino)propanamide, chloride |
Prilocaine hydrochloride, meets USP testing specifications |
o-Propionotoluidide, 2-(propylamino)-, hydrochloride, (+-)- |
(+-)-N-(2-Methylphenyl)-2-(propylamino)propanamide hydrochloride |
Prilocaine hydrochloride, European Pharmacopoeia (EP) Reference Standard |
Propanamide, N-(2-methylphenyl)-2-(propylamino)-, hydrochloride, (+-)- |
Prilocaine for peak identification, European Pharmacopoeia (EP) Reference Standard |
Prilocaine hydrochloride, United States Pharmacopeia (USP) Reference Standard |
2-(Propylamino)-o-propionotoluidide hydrochloride; N-(2-Methylphenyl)-2-(propylamino)-propanamide hydrochloride |
Experimental Data
Prilocaine hydrochloride
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 8.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
Prilocaine hydrochloride
Statistics Data
Prilocaine hydrochloride
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 8.000000000000000 | 1 | 1 |
Statistics Data Visualization
Prilocaine hydrochloride
